Diagnostic testing has contributed to exciting breakthroughs in technology and has simultaneously been an epicenter of risk as government and insurance companies seek to root out suspected fraud and abuse. Leech Tishman Nelson Hardiman has developed a significant reputation in advising laboratories on risk, compliance, and other business and regulatory issues.

Our attorneys have comprehensive experience guiding clients in building robust businesses and mitigating risk. We have the ability to handle complex crises and to address potentially damaging allegations as they arise. We routinely work with laboratories, physician office laboratories, and hospital laboratories, including specializations such as molecular diagnostics, genomics and genetics testing, toxicology drug testing, mobile diagnostics, full-panel allergen screening, and serology-based wellness assessments.

As market forces continue to drive consolidation in the diagnostics and reference laboratory industries, Leech Tishman Nelson Hardiman advises clients regarding complex mergers and acquisitions, provides regulatory guidance through the acquisition process, and handles issues related to changes of ownership (CHOWs).